Skip to main content
SpringerLink
Log in

Screening for H. pylori in patients at high risk of gastric cancer appears to be cost saving in the USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rustgi SD, et al. Testing and Treating Helicobacter Pylori Infection in Individuals with Family History of Gastric Cancer is Cost-effective. Gastroenterology : 27 Aug 2021. Available from: URL: http://doi.org/10.1053/j.gastro.2021.08.042

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Screening for H. pylori in patients at high risk of gastric cancer appears to be cost saving in the USA. PharmacoEcon Outcomes News 887, 24 (2021). https://doi.org/10.1007/s40274-021-08040-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08040-0

Search

Navigation